Users Discontinuing Anti-Obesity Injections Gain Back Pounds Four Times Faster Compared to People Using Diet and Exercise

Fresh analysis indicates that people who come off new slimming jabs like semaglutide or tirzepatide can put back on lost weight far faster than those who stop traditional lifestyle regimens.

Research printed in a leading health publication shows that while obese individuals often shed a large proportion of their body weight while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month after stopping.

"People using such drugs should be cognizant of the risk of rapid weight regain when the medication concludes," cautioned expert Dr. Susan Jebb.

This pace of recovery implies a reversion to pre-treatment weight in about one and a half years.

Analyzing Approaches

The analysis, which examined dozens of trials involving thousands of patients, contrasted the effects of GLP-1 agonists with conventional dieting.

Scientists note that people who shed pounds through lifestyle changes alone generally experience a slower creep back—around 0.1 kg a month—post-intervention.

Explaining the Rapid Rebound

Experts propose the mechanism of the drugs explains the amplified regain.

GLP-1 drugs mimic a body's own chemical called GLP-1, which moderates appetite.

"Sustained high doses of GLP-1 concentrations far above than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.

"Stopping of this GLP-1 'fix' leads to appetite is uncontrolled, making overeating far more likely."

An Ongoing Condition?

Health authorities recommend the injections for individuals with obesity-related health risks, alongside prescribed lifestyle changes.

Professionals argue that, considering the likelihood of relapse, the treatment is often ongoing.

This opinion is supported by drug manufacturers, who note that the findings "emphasize the persistent nature of excess weight," comparing it to managing conditions like high blood pressure.

User Testimonies

Individuals who have discontinued the medication explain a intense resurgence of hunger.

"It felt as if a switch that goes on and you're instantly extremely hungry," described an individual.

This difficulty is exacerbated if users have not established permanent lifestyle or habit modifications during therapy.

Widespread Interest

Figures suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with demand being substantial.

• Adoption is higher among women than men.
• The middle-aged demographic shows the greatest level of interest.
• Many obtain the drugs through private prescriptions rather than public health services.

Finally, experts emphasize that while the jabs are effective agents for shedding pounds, they are not a standalone solution and long-term success relies on ongoing lifestyle support.